|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-2-24
|
|
pubmed:abstractText |
To determine the response rate of patients with refractory/relapsed non-Hodgkin's lymphoma to treatment with elsamitrucin and to further characterize the toxic effects of elsamitrucin in this group of patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0167-6997
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
213-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8913843-Adult,
pubmed-meshheading:8913843-Aged,
pubmed-meshheading:8913843-Aged, 80 and over,
pubmed-meshheading:8913843-Aminoglycosides,
pubmed-meshheading:8913843-Anti-Bacterial Agents,
pubmed-meshheading:8913843-Antibiotics, Antineoplastic,
pubmed-meshheading:8913843-Female,
pubmed-meshheading:8913843-Humans,
pubmed-meshheading:8913843-Lymphoma, Non-Hodgkin,
pubmed-meshheading:8913843-Male,
pubmed-meshheading:8913843-Middle Aged
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphoma.
|
|
pubmed:affiliation |
North Shore University Hospital, Cornell University Medical College, Manhasset, NY, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
